Source and scope
This summary is bounded to the recommendations, population and decisions covered by Clinical diagnosis of benign paroxysmal positional vertigo and vestibular neuritis. Apply it with the current provincial or territorial pathway where implementation differs.
sources for this section:CMAJ BPPV
Source-attributed clinical priorities
- Use timing, triggers and targeted eye and neurologic examination to distinguish positional vertigo from a central syndrome.
- Confirm posterior-canal BPPV with positional testing when safe and treat with an appropriate canalith-repositioning manoeuvre.
- Escalate new focal deficits, inability to walk, severe headache, central nystagmus or an atypical course.
- The characteristic positional nystagmus pattern identifies the affected canal and the appropriate manoeuvre.
sources for this section:CMAJ BPPV
Practical assessment and management workflow
1
Clarify brief triggered episodes versus continuous vertigo and ask about hearing, headache, gait and neurologic symptoms.
2
Perform eye movements, gait and focused neurologic examination before positional testing.
3
Use the Dix-Hallpike or roll test when cervical and vascular safety permit.
4
Repeat the matched repositioning manoeuvre and reassess residual dizziness or an atypical response.
sources for this section:CMAJ BPPV
Safety, red flags and urgent escalation
- Continuous vertigo with severe gait inability, focal findings or new headache requires central-cause assessment.
- Do not rely on symptom description alone when stroke risk or abnormal examination is present.
- Avoid prolonged vestibular suppressants because they do not correct canalith disease and can increase falls.
sources for this section:CMAJ BPPV
Confirm the local pathway before acting
The evidence source is pan-Canadian, but formularies, funded access, referral routes, public-health directions and service availability remain provincial or territorial.
sources for this section:CMAJ BPPV
Source and implementation boundary
Read this educational summary with the linked source, current Canadian product information where medicines are involved, and the applicable provincial or territorial pathway. Local formularies, reporting duties, referral routes and service availability can differ.
sources for this section:CMAJ BPPV
Source documents
Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.
- Canadian Medical Association JournalClinical diagnosis of benign paroxysmal positional vertigo and vestibular neuritis2020;192:E182-E186 路 accessed 2026-08-20view source
continue the learning
From guidance to deliberate practice and evidence
Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.
Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the Canada question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.